The data could help the Enhertu regimen overtake a drug combination that’s been used as the initial treatment for ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

The leaked budget draft, if approved by Congress, would reduce the FDA’s budget authority, indicating more disruption could ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

The company’s board reiterated its recommendation to instead pursue an offer from SK Capital and Carlyle that’s worth about ...

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...

Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether ...

HHS bypassed normal procedures as it laid off thousands of employees, according to sources. One union has already filed an ...